According to Tatiana Nepomnyashchikh, deputy head of the Vector State Research Center of Virology and Biotechnology, the EpiVacCorona-N coronavirus vaccine will be placed into general circulation very soon, TASS reports.
The Vector Center’s EpiVacCorona-N coronavirus vaccine was certified by the Russian Ministry of Health on Thursday.
Rinat Maksyutov, the Center’s director, previously said that there are no significant changes between the EpiVacCorona and EpiVacCorona-N vaccinations. The vaccinations differ, according to Maksyutov, due to technological differences in the manufacturing process. Nonetheless, further clinical testing were required.
